SELECT B — Selectimmune Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- SEK41.38m
- SEK35.54m
Annual cashflow statement for Selectimmune Pharma AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 16 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.013 | -3.93 | -8.24 | -12.6 | -14.1 |
| Non-Cash Items | — | — | 0.076 | 0.399 | 0.399 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.012 | 2.23 | -1.72 | 1.71 | -1.7 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.001 | -1.7 | -9.89 | -10.5 | -15.4 |
| Capital Expenditures | — | — | -2 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | -2 | 0 | — |
| Financing Cash Flow Items | 0.05 | -3.49 | 0 | -0.202 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.05 | 36.5 | 0 | 14.1 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.049 | 34.8 | -11.9 | 3.6 | -15.4 |